Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + Leisure logo
Travel + LeisureTNL
18.8%+0.1pp
Belden logo
BeldenBDC
12.2%+0.5pp
Cabot Corporation logo
Cabot CorporationCBT
14.7%-6.0pp
Unifirst logo
UnifirstUNF
6.2%-0.9pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
3.4%+1.8pp
Liberty Broadband Corporation logo
Liberty Broadband CorporationLBRDK
-0.3%-0.1pp

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

$5.2Mtotal debt+$312.4Mtotal stockholders equity−$289.6Mcash and equivalents=$28.1M

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s invested capital?
Collegium Pharmaceutical, Inc. (COLL) reported invested capital of $28.1M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s invested capital changed year-over-year?
Collegium Pharmaceutical, Inc.'s invested capital decreased by 77.3% year-over-year, from $123.84M to $28.1M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s invested capital?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s invested capital has grown at a 20.8% compound annual growth rate (CAGR), from $21.41M to $55.06M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).